V. ÇINAR Et Al. , "Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1," Breast Cancer , vol.29, no.6, pp.1106-1120, 2022
ÇINAR, V. Et Al. 2022. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1. Breast Cancer , vol.29, no.6 , 1106-1120.
ÇINAR, V., HAMURCU, Z., Guler, A., Nurdinov, N., & Ozpolat, B., (2022). Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1. Breast Cancer , vol.29, no.6, 1106-1120.
ÇINAR, VENHAR Et Al. "Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1," Breast Cancer , vol.29, no.6, 1106-1120, 2022
ÇINAR, VENHAR Et Al. "Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1." Breast Cancer , vol.29, no.6, pp.1106-1120, 2022
ÇINAR, V. Et Al. (2022) . "Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1." Breast Cancer , vol.29, no.6, pp.1106-1120.
@article{article, author={VENHAR ÇINAR Et Al. }, title={Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1}, journal={Breast Cancer}, year=2022, pages={1106-1120} }